JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

F Zoulim, O Lenz, JJ Vandenbossche, W Talloen, T Verbinnen, I Moscalu, A Streinu-Cercel, S Bourgeois, M Buti, J Crespo, JM Pascasio, C Sarrazin, Thomas Vanwolleghem, U Shukla, J Fry, JZ Yogaratnam

Research output: Contribution to journalArticleAcademicpeer-review

62 Citations (Scopus)
Original languageEnglish
Pages (from-to)521-+
Issue number2
Publication statusPublished - 2020

Cite this